BioInvent signs monoclonal antibody manufacturing deal with Cantargia
Clinical stage firm BioInvent International and Cantargia have signed a manufacturing agreement for monoclonal antibody...
Apellis enters drug development and commercialisation deal with Sobi
Apellis Pharmaceuticals has entered into a strategic collaboration with Swedish Orphan Biovitrum (Sobi) to fast-track...
Eir Ventures launches to unlock the potential of the Nordics
Supported by three prestigious investment companies and the EU's EIF, Eir Ventures is a Nordic-based...
Medivir and SciLifeLab partner to identify Covid-19 drug candidates
Swedish drug development company Medivir has partnered with SciLifeLab, a life science research firm, to...
Piab
Piab is evolving automation through progressive gripping, lifting and moving solutions. We believe in an...
Cobra Biologics, Karolinska Institutet partner on Covid-19 vaccine
Cobra Biologics has partnered with the Karolinska Institutet in Sweden to develop a potential DNA...
Galen acquires Nordic-based POA Pharma in multi-million pound deal
Northern Ireland-based, globally focused pharmaceutical sales and marketing firm Galen has acquired Swedish-headquartered POA Pharma...
Cobra Biologics Manufacturing Facility Expansion, Matfors
Cobra Biologics, a contract development and manufacturing organisation (CDMO), is expanding its manufacturing facility located...
Sobi to purchase Dova Pharmaceuticals in $915m deal
Swedish Orphan Biovitrum AB (Sobi) has agreed to acquire US-based Dova Pharmaceuticals in a transaction...
Moberg Pharma signs deal with Taisho for MOB-015 development
Swedish company Moberg Pharma has signed an agreement with Taisho Pharmaceutical towards the development, registration...